213 related articles for article (PubMed ID: 27777008)
1. Syntheses, cytotoxic activity evaluation and HQSAR study of 1,2,3-triazole-linked isosteviol derivatives as potential anticancer agents.
Liu CJ; Liu YP; Yu SL; Dai XJ; Zhang T; Tao JC
Bioorg Med Chem Lett; 2016 Nov; 26(22):5455-5461. PubMed ID: 27777008
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxic activity evaluation and HQSAR study of novel isosteviol derivatives as potential anticancer agents.
Liu CJ; Yu SL; Liu YP; Dai XJ; Wu Y; Li RJ; Tao JC
Eur J Med Chem; 2016 Jun; 115():26-40. PubMed ID: 26994841
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, cytotoxic activity, and 2D- and 3D-QSAR studies of 19-carboxyl-modified novel isosteviol derivatives as potential anticancer agents.
Liu CJ; Zhang T; Yu SL; Dai XJ; Wu Y; Tao JC
Chem Biol Drug Des; 2017 Jun; 89(6):870-887. PubMed ID: 27878967
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.
Khaybullin RN; Liang X; Cisneros K; Qi X
Future Med Chem; 2015; 7(18):2419-28. PubMed ID: 26653151
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of isosteviol triazole conjugates for cancer therapy.
Khaybullin RN; Zhang M; Fu J; Liang X; Li T; Katritzky AR; Okunieff P; Qi X
Molecules; 2014 Nov; 19(11):18676-89. PubMed ID: 25405286
[TBL] [Abstract][Full Text] [Related]
6. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation.
Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC
Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic activity of MOM-ether analogs of isosteviol.
Malki A; Laha R; Bergmeier SC
Bioorg Med Chem Lett; 2014 Feb; 24(4):1184-7. PubMed ID: 24444475
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives.
Wang TT; Liu Y; Chen L
Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
Hou W; Fan Q; Su L; Xu H
Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
[TBL] [Abstract][Full Text] [Related]
11. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of C-19 Isosteviol Derivatives as Potent and Highly Selective Antiproliferative Agents.
Luan T; Cao LH; Deng H; Shen QK; Tian YS; Quan ZS
Molecules; 2018 Dec; 24(1):. PubMed ID: 30598028
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.
Ke Y; Liang JJ; Hou RJ; Li MM; Zhao LF; Wang W; Liu Y; Xie H; Yang RH; Hu TX; Wang JY; Liu HM
Eur J Med Chem; 2018 Sep; 157():1249-1263. PubMed ID: 30193221
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel oridonin analogues as potent anticancer agents.
Shen QK; Chen ZA; Zhang HJ; Li JL; Liu CF; Gong GH; Quan ZS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):324-333. PubMed ID: 29303372
[TBL] [Abstract][Full Text] [Related]
15. Glycosides and Glycoconjugates of the Diterpenoid Isosteviol with a 1,2,3-Triazolyl Moiety: Synthesis and Cytotoxicity Evaluation.
Andreeva OV; Garifullin BF; Sharipova RR; Strobykina IY; Sapunova AS; Voloshina AD; Belenok MG; Dobrynin AB; Khabibulina LR; Kataev VE
J Nat Prod; 2020 Aug; 83(8):2367-2380. PubMed ID: 32786882
[TBL] [Abstract][Full Text] [Related]
16. Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids.
Hou W; Luo Z; Zhang G; Cao D; Li D; Ruan H; Ruan BH; Su L; Xu H
Eur J Med Chem; 2017 Sep; 138():1042-1052. PubMed ID: 28759877
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro cytotoxic activity evaluation of novel heterocycle bridged carbothioamide type isosteviol derivatives as antitumor agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Bioorg Med Chem Lett; 2013 Mar; 23(5):1343-6. PubMed ID: 23347685
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents.
Yang J; Liu Y; Xue C; Yu W; Zhang J; Qiao C
Eur J Med Chem; 2014 Oct; 86():235-41. PubMed ID: 25164762
[TBL] [Abstract][Full Text] [Related]
19. Rapid synthesis of triazole-modified resveratrol analogues via click chemistry.
Pagliai F; Pirali T; Del Grosso E; Di Brisco R; Tron GC; Sorba G; Genazzani AA
J Med Chem; 2006 Jan; 49(2):467-70. PubMed ID: 16420033
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 1,2,4-triazole and 1,3,4-thiadiazole derivatives as potential cytotoxic agents.
Shi YJ; Song XJ; Li X; Ye TH; Xiong Y; Yu LT
Chem Pharm Bull (Tokyo); 2013; 61(11):1099-104. PubMed ID: 23934258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
